Literature DB >> 17459924

Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.

Kening Wang1, Gowtham Mahalingam, Susan E Hoover, Erik K Mont, Steven M Holland, Jeffrey I Cohen, Stephen E Straus.   

Abstract

Mutations in the thymidine kinase gene (tk) of herpes simplex virus type 1 (HSV-1) explain most cases of virus resistance to acyclovir (ACV) treatment. Mucocutaneous lesions of patients with ACV resistance contain mixed populations of tk mutant and wild-type virus. However, it is unknown whether human ganglia also contain mixed populations since the replication of HSV tk mutants in animal neurons is impaired. Here we report the detection of mutated HSV tk sequences in human ganglia. Trigeminal and dorsal root ganglia were obtained at autopsy from an immunocompromised woman with chronic mucocutaneous infection with ACV-resistant HSV-1. The HSV-1 tk open reading frames from ganglia were amplified by PCR, cloned, and sequenced. tk mutations were detected in a seven-G homopolymer region in 11 of 12 ganglia tested, with clonal frequencies ranging from 4.2 to 76% HSV-1 tk mutants per ganglion. In 8 of 11 ganglia, the mutations were heterogeneous, varying from a deletion of one G to an insertion of one to three G residues, with the two-G insertion being the most common. Each ganglion had its own pattern of mutant populations. When individual neurons from one ganglion were analyzed by laser capture microdissection and PCR, 6 of 14 HSV-1-positive neurons were coinfected with HSV tk mutants and wild-type virus, 4 of 14 were infected with wild-type virus alone, and 4 of 14 were infected with tk mutant virus alone. These data suggest that diverse tk mutants arise independently under drug selection and establish latency in human sensory ganglia alone or together with wild-type virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459924      PMCID: PMC1933309          DOI: 10.1128/JVI.00166-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus.

Authors:  S M Swetter; E L Hill; E R Kern; D M Koelle; C M Posavad; W Lawrence; S Safrin
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

2.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

Authors:  A T Jamieson; G A Gentry; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

4.  Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.

Authors:  M Saijo; T Suzutani; K Itoh; Y Hirano; K Murono; M Nagamine; K Mizuta; M Niikura; S Morikawa
Journal:  J Med Virol       Date:  1999-08       Impact factor: 2.327

5.  Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.

Authors:  Růzena Stránská; Rob Schuurman; Elske Nienhuis; Irma W Goedegebuure; Merjo Polman; Jan F Weel; Pauline M Wertheim-Van Dillen; Ron J M Berkhout; Anton M van Loon
Journal:  J Clin Virol       Date:  2005-01       Impact factor: 3.168

6.  Acyclovir sensitivity of sequential herpes simplex virus type 2 isolates from the genital mucosa of immunocompetent women.

Authors:  Rachna Gupta; Edgar L Hill; Dan McClernon; Gray Davis; Stacy Selke; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2005-08-10       Impact factor: 5.226

7.  Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis?

Authors:  B C Horsburgh; S H Chen; A Hu; G B Mulamba; W H Burns; D M Coen
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

8.  Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.

Authors:  Růzena Stránská; Anton M van Loon; Merjo Polman; Matthias F C Beersma; Robbert G M Bredius; Arjan C Lankester; Ellen Meijer; Rob Schuurman
Journal:  Antivir Ther       Date:  2004-08

9.  Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains.

Authors:  E Kudo; H Shiota; T Naito; K Satake; M Itakura
Journal:  J Med Virol       Date:  1998-10       Impact factor: 2.327

10.  Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.

Authors:  Růzena Stránská; Anton M van Loon; Robbert G M Bredius; Merjo Polman; Elske Nienhuis; Matthias F C Beersma; Arjan C Lankester; Rob Schuurman
Journal:  Antivir Ther       Date:  2004-02
View more
  16 in total

1.  The herpes simplex virus 2 virion-associated ribonuclease vhs interferes with stress granule formation.

Authors:  Renée L Finnen; Thomas J M Hay; Bianca Dauber; James R Smiley; Bruce W Banfield
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

2.  Development and evaluation of SYBR Green-I based quantitative PCR assays for herpes simplex virus type 1 whole transcriptome analysis.

Authors:  Cathryn E Garvey; Chris L McGowin; Timothy P Foster
Journal:  J Virol Methods       Date:  2014-03-04       Impact factor: 2.014

Review 3.  CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?

Authors:  Harshana S De Silva Feelixge; Daniel Stone; Pavitra Roychoudhury; Martine Aubert; Keith R Jerome
Journal:  ACS Infect Dis       Date:  2018-03-21       Impact factor: 5.084

4.  Antiviral activity of recombinant cyanovirin-N against HSV-1.

Authors:  Hong Yu; Zong-tao Liu; Rui Lv; Wen-qing Zhang
Journal:  Virol Sin       Date:  2010-12-21       Impact factor: 4.327

Review 5.  DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.

Authors:  Nicholas D Weber; Martine Aubert; Chung H Dang; Daniel Stone; Keith R Jerome
Journal:  Virology       Date:  2014-01-31       Impact factor: 3.616

Review 6.  Targeted DNA mutagenesis for the cure of chronic viral infections.

Authors:  Joshua T Schiffer; Martine Aubert; Nicholas D Weber; Esther Mintzer; Daniel Stone; Keith R Jerome
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

7.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Laura Olin; Meei-Li Huang; Lawrence Corey
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

8.  The application of laser microdissection in molecular detection and identification of aspergillus fumigatus from murine model of acute invasive pulmonary aspergillosis.

Authors:  Chong Wang; Ping Zhan; Le Wang; Rong Zeng; Yongnian Shen; Guixia Lv; Dongmei Li; Shuwen Deng; Weida Liu
Journal:  Mycopathologia       Date:  2014-06-29       Impact factor: 2.574

Review 9.  Novel aspects of corneal angiogenic and lymphangiogenic privilege.

Authors:  David Ellenberg; Dimitri T Azar; Joelle A Hallak; Faisal Tobaigy; Kyu Yeon Han; Sandeep Jain; Zhongjun Zhou; Jin-Hong Chang
Journal:  Prog Retin Eye Res       Date:  2010-01-25       Impact factor: 21.198

10.  Evolution and diversity in human herpes simplex virus genomes.

Authors:  Moriah L Szpara; Derek Gatherer; Alejandro Ochoa; Benjamin Greenbaum; Aidan Dolan; Rory J Bowden; Lynn W Enquist; Matthieu Legendre; Andrew J Davison
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.